AAAAAA
Results:
1-15
|
Results: 15
Authors:
Fattovich, G
Ribero, ML
Pantalena, M
Diodati, G
Almasio, P
Nevens, F
Tremolada, F
Degos, F
Rai, J
Solinas, A
Mura, D
Tocco, A
Zagni, I
Fabris, F
Lomonaco, L
Noventa, F
Realdi, G
Schalm, SW
Tagger, A
Citation: G. Fattovich et al., Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in Europe, J VIRAL HEP, 8(3), 2001, pp. 206-216
Authors:
Degos, F
Pol, S
Chaix, ML
Laffitte, V
Buffet, C
Bernard, PH
Degott, C
Carnot, F
Riffaud, PC
Chevret, S
Citation: F. Degos et al., The tolerance and efficacy of interferon-alpha in haemodialysis patients with HCV infection: a multicentre, prospective study, NEPH DIAL T, 16(5), 2001, pp. 1017-1023
Authors:
Di Martino, V
Rufat, P
Boyer, N
Renard, P
Degos, F
Martinot-Peignoux, M
Matheron, S
Le Moing, V
Vachon, F
Degott, C
Valla, D
Marcellin, P
Citation: V. Di Martino et al., The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: A long-term retrospective cohort study, HEPATOLOGY, 34(6), 2001, pp. 1193-1199
Authors:
Pessione, F
Ramond, MJ
Njapoum, C
Duchatelle, V
Degott, C
Erlinger, S
Rueff, B
Valla, DC
Degos, F
Citation: F. Pessione et al., Cigarette smoking and hepatic lesions in patients with chronic hepatitis C, HEPATOLOGY, 34(1), 2001, pp. 121-125
Authors:
Cadranel, JF
Rufat, P
Degos, F
Citation: Jf. Cadranel et al., The risks of percutaneous liver biopsy - Reply, HEPATOLOGY, 33(3), 2001, pp. 764-764
Authors:
Valla, DC
Degos, F
Citation: Dc. Valla et F. Degos, Chemoprevention of hepatocellular carcinoma in hepatitis C virus-related cirrhosis: first, eliminate the virus, J HEPATOL, 34(4), 2001, pp. 606-609
Authors:
Cadranel, JF
Rufat, P
Degos, F
Citation: Jf. Cadranel et al., Practices of liver biopsy in France: Results of a prospective nationwide survey, HEPATOLOGY, 32(3), 2000, pp. 477-481
Authors:
Bralet, MP
Regimbeau, JM
Pineau, P
Dubois, S
Loas, G
Degos, F
Valla, D
Belghiti, J
Degott, C
Terris, B
Citation: Mp. Bralet et al., Hepatocellular carcinoma occurring in nonfibrotic liver: Epidemiologic andhistopathologic analysis of 80 French cases, HEPATOLOGY, 32(2), 2000, pp. 200-204
Authors:
Di Martino, V
Thevenot, T
Boyer, N
Degos, F
Valla, D
Marcellin, P
Citation: V. Di Martino et al., Serum alanine transaminase level is a good predictor of response to interferon alfa therapy for chronic hepatitis B in human immunodeficiency virus-infected patients, HEPATOLOGY, 31(4), 2000, pp. 1030-1031
Authors:
Degos, F
Christidis, C
Ganne-Carrie, N
Farmachidi, JP
Degott, C
Guettier, C
Trinchet, JC
Beaugrand, M
Chevret, S
Citation: F. Degos et al., Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death, GUT, 47(1), 2000, pp. 131-136
Authors:
Poynard, T
Daurat, V
Chevret, S
Moussalli, J
Degos, F
Bailly, F
Borotto, E
Buffet, C
Bartolomei-Portal, I
Richardet, JP
Riachi, G
Calmus, Y
Brechot, C
Vidaud, M
Olivi, M
Bedossa, P
Riffaud, PC
Chastang, C
Citation: T. Poynard et al., A short induction regimen of interferon-alpha is not effective for treatment of relapse in chronic hepatitis C: a randomized trial, J VIRAL HEP, 6(5), 1999, pp. 381-386
Authors:
Degos, F
Citation: F. Degos, The benefit-risk politics of vaccination against hepatitis B virus, ITAL J GAST, 31(5), 1999, pp. 392-394
Authors:
Naveau, S
Balian, A
Degos, F
Daurat, V
Chevret, S
Gayno, S
Bastie, A
Riachi, G
Bartolomei-Portal, I
Barange, K
Moussalli, J
Bailly, F
Chaumet-Riffaud, P
Emilie, D
Citation: S. Naveau et al., Prognostic value of the soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alfa, J HEPATOL, 31(4), 1999, pp. 612-617
Authors:
Marcellin, P
Alberti, A
Dusheiko, G
Esteban, R
Manns, M
Shouval, D
Weiland, O
Williams, R
Benhamou, JP
Rodes, J
Alter, H
Bismuth, H
Desmet, V
Guardia, J
Heathcote, J
Lok, A
Maddrey, WC
Zum Buschenfelde, KHM
Pagliaro, L
Paumgartner, G
Sherlock, S
Abrignani, S
Alberti, A
Alter, M
Bonino, F
Bortolotti, F
Brechot, C
de Moura, MC
Carreno, V
Colombo, M
Craxi, A
Davis, G
De Francesco, R
Degos, F
Di Bisceglie, A
Dienes, H
Dusheiko, G
Esteban, J
Esteban, R
Farci, P
Ferrari, C
Foster, G
Hadziyannis, S
Hoofnagle, J
Koff, R
Lavanchy, D
Lindsay, K
Lunel, F
Manns, M
Marcellin, P
Mondelli, M
Nalpas, B
Naoumov, N
Pawlotsky, JM
Pol, S
Pontisso, P
Poynard, T
Prieto, J
Rizzetto, M
Roggendorf, M
Moreno, MR
Samuel, D
Sanchez-Tapias, J
Schalm, S
Shouval, D
Simmonds, P
Soriano, V
Tassopoulos, N
Thomas, H
Trepo, C
Van der Poel, CL
Vogel, W
Weiland, O
Wejstal, R
Williams, R
Wright, T
Zanetti, A
Zarski, JP
Zeuzem, S
Zoulim, F
Citation: P. Marcellin et al., EASL International Consensus Conference on Hepatitis C - Paris, 26-27 February 1999 - Consensus statement (Reprinted from Journal of Hematology, vol 30, pg 956-961, 1999), J HEPATOL, 31, 1999, pp. 3-8
Authors:
Degos, F
Citation: F. Degos, Hepatitis C and alcohol, J HEPATOL, 31, 1999, pp. 113-118
Risultati:
1-15
|